Advertisement
Most Read Articles
>> Alpharetta church organist says he was forced to resign for being gay>> Petition pops up urging Atlanta City Council to outlaw sex shops on Cheshire Bridge Road
>> Ga. Rep. Simone Bell named a 'Harvey Milk Champion of Change'
>> 'Soft' benefits only for domestic partners at UGA
>> Lesbian poet Theresa Davis celebrates release of new book 'After This We Go Dark'
Advertisement
LGBT Blogroll
-
What You Need To Know This Week (5/19 - 5/25)
The Bilerico Project | 25 May 2013 | 3:00 pm
-
Openly Gay Pro Soccer Player Robbie Rogers To Join Los Angeles Galaxy
Joe. My. God. | 25 May 2013 | 2:52 pm
-
Picture book teaches children of ‘God’s plan’ to demonize LGBT families
LGBTQ Nation | 25 May 2013 | 12:30 pm
-
NOM's Brian Brown Says Ending Gay Ban On Scouts Will Sexualize The Boy Scouts
On Top Magazine Headlines | 25 May 2013 | 12:25 pm
-
WATCH: The Fire Island Pines Pavilion — Rebuilding An Icon
Queerty | 25 May 2013 | 7:26 am
Advertisement
| HIV researcher moves forward with vaccine trial |
| by Ryan Watkins | ||||
| December 13, 2011 17:45 | ||||
|
GeoVax Labs, an Atlanta-based biotechnology company, today announced a major milestone in its quest to eliminate the HIV virus, as the first patient has been inoculated with the company's HIV/AIDS vaccine following success in post-vaccine viral control in primates. The company's vaccine is aimed at stimulating the body's immune system to resist the spread of infection. "Dosing the first study participant marks a major milestone for our Phase 1/2 clinical trial. We are pleased to have the AIDS Research Consortium of Atlanta, the Alabama Vaccine Research Center at the University of Alabama, Birmingham, and the AIDS Research Alliance of Los Angeles participating in the trial,” said Robert McNally, president and CEO of GeoVax Labs, in a prepared statement. “These three trial sites are actively seeking persons who are interested in and fit the criteria for the study," McNally added. GeoVax is currently enrolling participants in the clinical trial, which is being conducted at the AIDS Research Consortium of Atlanta, the company announced. For more information on GeoVax and for information on signing up for its clinical trial, visit www.geovax.com.
|
